Sarepta Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $9.8M | 78k | 124.89 |
| 2024-06-30 | $9.5M | 60k | 158.00 |
| 2024-03-31 | $266k | 2.1k | 129.46 |
| 2023-09-30 | $9.5M | 79k | 121.22 |
| 2023-06-30 | $11M | 98k | 114.52 |
| 2023-03-31 | $17M | 120k | 137.83 |
| 2022-12-31 | $15M | 116k | 129.58 |
| 2022-09-30 | $17M | 158k | 110.54 |
| 2022-06-30 | $1.3M | 18k | 74.94 |
| 2021-03-31 | $386k | 5.2k | 74.46 |
| 2020-12-31 | $1.3M | 7.5k | 170.47 |
| 2020-09-30 | $1.2M | 8.5k | 140.40 |
| 2018-09-30 | $250k | 1.6k | 161.29 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management